Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV

Journal of Clinical Investigation

Volumn 99, Issue 8, 1997, Pages 1906-1916

  Cohen, Robert D ^a   Castellani, Lawrence W ^b   Qiao, Jian Hua ^b   Van Lenten, Brian J ^b   Lusis, Aldons J ^b   Reue, Karen ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

apo A IV; atherosclerosis; cellular cholesterol efflux; lipoproteins; transgene

Indexed keywords

APOLIPOPROTEIN A4; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTERIFICATION; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERLIPOPROTEINEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030944085     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119358     Document Type: Article

References (60)

1. Miller, N.E. 1980. HDL cholesterol, tissue cholesterol, and coronary atherosclerosis: epidemiological correlations. In Atherosclerosis. A.M. Gotto, Jr. and B. Allen, editors. Springer Publishing Co., New York. 500-503.
2. Breslow, J.L. 1994. Lipoprotein metabolism and atherosclerosis susceptibility in transgenic mice. Curr. Opin. Lipid. 5:175-184.
3. Paigen, B., A.S. Plump, and E.M. Rubin. 1994. The mouse as a model for human cardiovascular disease and hyperlipidemia. Curr. Opin. Lipid. 5:258-264.
4. Schultz, J.R., and E.M. Rubin, 1994. The properties of HDL in genetically engineered mice. Curr. Opin. Lipid. 5:126-137.
5. Rubin, E.M., R.M. Krauss, E.A. Spangler, J.G. Verstuyft, and S.M. Clift. 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature (Lond.). 353:265-267.
6. Warden, C.H., C.C. Hedrick, J.-H. Qiao, L.W. Castellani, and A.J. Lusis. 1993. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science (Wash. DC). 261:469-472.
7. Schultz, J.R., J.G. Verstuyft, E.L. Gong, A.V. Nichols, and E.M. Rubin. 1993. Protein composition determines the anti-atherogenic properties of high density lipoproteins in transgenic mice. Nature (Lond.). 365:761-764.
8. Bisgaier, C.L., O.P. Sachdev, L. Megna, and R.M. Glickman. 1985. Distribution of apolipoprotein A-IV in human plasma. J. Lipid Res. 26:11-25.
9. Vezina, C.A., R.W. Milne, P.K. Weech, and Y.L. Marcel. 1988. Apolipoprotein distribution in human lipoproteins separated by polyacrylamide gradient gel electrophoresis. J. Lipid Res. 29:573-585.
10. Lagrost, L., P. Gambert, M. Boquillon, and C. Lallemant. 1989. Evidence for high density lipoproteins as the major apolipoprotein A-IV-containing fraction in normal human serum. J. Lipid Res. 30:1525-1534.
11. Duverger, N., N. Ghalim, G. Ailhaud, A. Steinmetz, J.-C. Fruchart, and G. Castro. 1993. Characterization of apo A-IV-containing lipoprotein particles isolated from human plasma and interstitial fluid. Arterioscler. Thromb. 13: 126-132.
12. Weinberg, R.B., and M.S. Spector. 1985. Structural properties and lipid binding of human apolipoprotein A-IV. J. Biol. Chem. 260:4914-4921.
13. Utermann, G., and U. Beisiegel. 1979. Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification. Eur. J. Biochem. 99:333-343.
14. Lefevre, M., and P.S. Roheim. 1984. Metabolism of apolipoprotein A-IV. J. Lipid Res. 25:1603-1610.
15. Elshourbagy, N.A., M.S. Boguski, W.S.L. Liao, L.S. Jefferson, J.I. Gordon, and J.M. Taylor. 1985. Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin. Proc. Natl. Acad. Sci. USA. 82:8242-8246.
16. Ghiselli, G., S. Krishnan, Y. Beigel, and A.M. Gotto, Jr. 1986. Plasma metabolism of apolipoprotein A-IV in humans. J. Lipid Res. 27:813-827.
17. Steinmetz, A., and G. Utermann. 1985. Activation of lecithin cholesterol acyltransferase by human apolipoprotein A-IV. J. Biol. Chem. 260:2258-2264.
18. Chen, C.H., and J.J. Albers. 1985. Activation of lecithin cholesterol acyltransferase by human apolipoproteins E-2, E-3, and A-IV. Biochim. Biophys. Acta. 836:279-285.
19. Goldberg, I.J., C.A. Scheraldi, L.K. Yacoub, U. Saxena, and C.L. Bisgaier. 1990. Lipoprotein apo C-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J. Biol. Chem. 265:4266-4272.
20. DeLamatre, J.G., C.A. Hoffmeier, A.G. Lacko, and P.S. Roheim. 1983. Distribution of apolipoprotein A-IV between the lipoprotein and lipoprotein-free fractions of rat plasma: possible role of lecithin:cholesterol acyltransferase. J. Lipid Res. 24:1578-1585.
21. Bisgaier, C.L., O.P. Sachdev, E.S. Lee, K.J. Williams, C.B. Blum, and R.M. Glickman. 1987. Effect of lecithin:cholesterol acyltransferase on distribution of apolipoprotein A-IV among lipoproteins of human plasma. J. Lipid Res. 28:693-703.
22. Weinberg, R.B., J.A. Ibdah, and M.C. Phillips. Adsorption of apolipoprotein A-IV to phospholipid monolayers spread at the air/water interface. A model for its labile binding to high density lipoproteins. J. Biol. Chem. 267: 8977-8983.
23. Stein, O., Y. Stein, M. Lefevre, P.S. Roheim. 1986. The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochim. Biophys. Acta. 878:7-14.
24. Steinmetz, A., R. Barbaras, N. Ghalim, V. Clavey, J.-C. Fruchart, and G. Ailhaud. 1990. Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J. Biol. Chem. 265:7859-7863.
25. Fujimoto, K., J.A. Cardelli, and P. Tso. 1992. Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am. J. Physiol. 262:G1002-G1006.
26. Fujimoto, K., K. Fukagawa, T. Sakata, and P. Tso. 1993. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J. Clin. Invest. 91:1830-1833.
27. Aalto-Setälä, K., C.L. Bisgaier, A. Ho, K.A. Kieft, M.G. Traber, H.J. Kayden, R. Ramakrishnan, A. Walsh, A.D. Essenburg, and J.L. Breslow. 1994. Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. J. Clin. Invest. 93:1776-1786.
28. Reue, K., D.A. Purcell-Huynh, T.H. Leete, M.H. Doolittle, A. Durstenfeld, and A.J. Lusis. 1993. Genetic variation in mouse apolipoprotein A-IV expression is determined pre- and post-transcriptionally. J. Lipid Res. 34:893-903.
29. Reue, K., and S. Rehnmark. 1994. Screening transgenic mice by PCR: detection of tandem repeats. Biotechniques. 17:252-253.
30. Reue, K., and T.H. Leete. 1991. Genetic variation in mouse apolipoprotein A-IV due to insertion and deletion in a region of tandem repeats. J. Biol. Chem. 266:12715-12721.
31. LeBoeuf, R.C., M.H Doolittle, A. Montcalm, D.C. Martin, K. Reue, and A.J. Lusis. 1990. Phenotypic characterization of the Ath-1 gene controlling high density lipoprotcin levels and susceptibility to atherosclerosis. J. Lipid Res. 31:91-101.
32. Hedrick, C.C., L.W. Castellani, C.H. Warden, D.L. Puppione, and A.J. Lusis. 1993. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice. J. Biol. Chem. 268:20676-20682.
33. Jiao, S., T.G. Cole, R.T. Kitchens, B. Pfleger, and G. Schonfeld. 1990. Genetic heterogeneity of plasma lipoproteins in the mouse: control of low density lipoprotein particle sizes by genetic factors. J. Lipid Res. 31:467-477.
34. Qiao, J.H., P.Z. Xie, M.C. Fishbein, J. Kreuzer, T.A. Drake, L.L. Demer, and A.J. Lusis. 1994. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscler. Thromb. 14:1480-1497.
35. Bernard, D.W., A. Rodriguez, G.H. Rothblatt, and J.M. Glick. 1990. Influence of high density lipoprotein on esterified cholesterol stores in macrophages and hepatoma cells. Arteriosclerosis. 10:135-144.
36. Navab, M., G.P. Hough, L.W. Stevenson, D.C. Drinkwater, H. Laks, and A.M. Fogelman. 1988. Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J. Clin. Invest. 82:1853-1863.
37. Van Lenten, B.J., S.Y. Hama, F.C. de Beer, D.M. Stafforini, T.M. McIntyre, S.M. Prescott, B.N. La Du, A.M. Fogelman, and M. Navab. 1995. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall co-cultures. J. Clin. Invest. 96:2758-2767.
38. Ohta, T., R. Nakamura, K. Takata, Y. Saito, S. Yamashita, S. Horiuchi, and I. Matsuda. 1995. Structural and functional differences of subspecies of apoAI-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency. J. Lipid Res. 36:696-704.
39. Walsh, A., N. Azrolan, K. Wang, A. Marcigliano, A. O'Connell, and J.L. Breslow. 1993. Intestinal expression of the human apo A-I gene in transgenic mice is controlled by a DNA region 3′ to the gene in the promoter of the adjacent convergently transcribed apo C-III gene. J. Lipid Res. 34:617-623.
40. Berliner, J.A., M. Navah, A.M. Fogelman, J.S. Frank, L.L. Demer, P.A. Edwards, A.D. Watson, and A.J. Lusis. 1995. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 91:2488-2496.
41. Mackness, M.I., S. Arrol, and P.N. Durrington. 1991. Paraoxonase prevents accumulation of lipoperoxides in low density lipoprotein FEBS Lett. 286: 152-154.
42. Watson, A.D., M. Navab, S.Y. Hama, A. Sevanian, S.M. Prescott, D.M. Stafforini, T.M. McIntyre, B.N. La Du, A.M. Fogelman, and J.A. Berliner. 1995. Effect of platelet activating factor-acetylhydrolase on the production and activity of mildly oxidized low density lipoprotein. J. Clin. Invest. 95:774-782.
43. Fielding, C.J., and P.E. Fielding. 1981. Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecithin: cholesterol acyltransferase. Proc. Natl. Acad. Sci. USA. 78: 3911-3914.
44. Schultz, J.R., J.G. Verstuyft, E.L. Gong, A.V. Nichols, and E.M. Rubin. 1992. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice. J. Biol. Chem. 267:21630-21636.
45. Bisaha, J.G., T.C. Simon, J.I. Gordon, and J.L. Breslow. 1995. Characterization of an enhancer element in the human apolipoprotein C-III gene that regulates human apolipoprotein A-I gene expression in the intestinal epithelium. J. Biol. Chem. 270:19979-19988.
46. Ishida, B.Y., P.J. Blanche, A.V. Nichols, M. Yashar, and B. Paigen. 1991. Effects of atherogenic diet consumption of lipoproteins in mouse strains C57BL/6 and C3H. J. Lipid Res. 32:559-568.
47. Plump, A.S., J.D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J.G. Verstuyft, E.M. Rubin, and J.L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:343-353.
48. Mehlum, A., B. Staels, N. Duverger, A. Tailleux, G. Castro, C. Fievet, G. Luc, J.-C. Fruchart, G. Olivecrona, G. Skretting, et al. 1995. Tissue-specific expression of the human gene for lecithin:cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases toward a less atherogenic profile. Eur. J. Biochem. 230:567-575.
49. Francone, O.L., E.L. Gong, D.S. Ng, C.J. Fielding, and E.M. Rubin. 1995. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein A-I and human apolipoprotein A-II on plasma lipoprotein cholesterol metabolism. J. Clin. Invest. 96:1440-1448.
50. Weinberg, R.B., and C.S. Patton. 1990. Binding of human apolipoprotein A-IV to human hepatocellular plasma membranes. Biochim. Biophys. Acta. 1044:255-261.
51. Duverger, N., N. Ghalim, G. Ailhaud, A. Steinmetz, J.-C. Fruchart, and G. Castro. 1993. Characterization of apo A-IV-containing lipoprotein particles isolated from human plasma and interstitial fluid. Arterioscler. Thromb. 13: 126-132.
52. von Eckardstein, A., Y. Huang, S. Wu, A.S. Sarmadi, S. Schwarz, A. Steinmetz, and G. Assmann. 1995. Lipoproteins containing apolipoprotein A-IV but not apolipoprotein A-I take up and esterify cell-derived cholesterol in plasma. Arterioscler. Thromb. 15:1755-1763.
53. Stampfer, M.J., P.M. Sacks, S. Salvini, W.C. Willett, and C.H. Hennekens. 1991. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N. Engl. J. Med. 325:373-381.
54. Li, H., R.L. Reddick, and N. Maeda. 1993. Lack of apo A-I is not associated with increased susceptibility to atherosclerosis in mice. Arterioscler. Thromb. 13:1814-1821.
55. Sloop, C.H., L. Dory, and P.S. Roheim. 1987. Interstitial fluid lipoproteins. J. Lipid Res. 28:225-237.
56. Sloop, C.H., L. Dory, R. Hamilton, B.R. Krause, and P.S. Roheim. 1983. Characterization of dog peripheral lymph lipoproteins: the presence of a disc-shaped "nascent" high density lipoprotein. J. Lipid Res. 24:1429-1440.
57. Roheim, P.S., D. Edelstein, and G.G. Pinter. 1976. Apolipoproteins in rat serum and renal lymph. Proc. Natl. Acad. Sci. USA. 73:1757-1760.
58. Buchberg, A.M., and A.J. Kinniburgh. 1985. Induction of liver apolipoprotein A-IV mRNA in porphyric mice. Nucleic Acids Res. 13:1953-1963.
59. Langner, C.A., E.H. Birkenmeier, O. Ben-Zeev, M.C. Schotz, H.O. Sweet, M.T. Davisson, and J.I. Gordon. 1989. The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities. J. Biol. Chem. 264:7994-8003.
60. Duverger, N., G. Tremp, J.-M. Caillaud, F. Emmanuel, G. Castro, J.-C. Fruchart, A. Steinmetz, and P. Denéfle. 1996. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science (Wash. DC.). 273: 966-968.